Application 219395
- Type
- ANDA
- Sponsor
- SPECGX LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | TOFACITINIB | TOFACITINIB CITRATE | TABLET | 5MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219395-001 | TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 5MG BASE | TABLET / ORAL | AB | 2026-06-03 | |
| A219395-002 | TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2026-06-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219395-001 | AB |
| A219395-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A219395-001 | TOFACITINIB CITRATE | EQ 5MG BASE | TABLET / ORAL | AB | 2026-06-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219395-002 | TOFACITINIB CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2026-06-03 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219395-001 | TOFACITINIB CITRATE | EQ 5MG BASE | TABLET / ORAL | AB | 2026-06-03 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219395-002 | TOFACITINIB CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2026-06-03 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A219395-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219395-002 | AB | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219395-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219395-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TOFACITINIB | TOFACITINIB | Golden State Medical Supply, Inc. | 58b94979-55ad-839a-e063-6294a90ad812 | 2026-08-24 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB |
| Tofacitinib | TOFACITINIB | Edenbridge Pharmaceuticals LLC. | 576722e5-6639-452d-a5c3-33a064f19481 | 2026-08-17 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| Tofacitinib | TOFACITINIB | Golden State Medical Supply, Inc. | 58f22c41-87d2-e745-e063-6394a90a962e | 2026-08-13 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| Tofacitinib | TOFACITINIB | Novadoz Pharmaceuticals LLC | 253635c8-1ea7-41ba-b216-dea5e3305c47 | 2026-08-13 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| tofacitinib | TOFACITINIB | Zydus Pharmaceuticals USA Inc. | 179ffbb2-bedc-40e6-b77b-33d4f7832172 | 2026-08-07 | Boxed warning, Warnings, Adverse reactions | tofacitinib |
| Tofacitinib | TOFACITINIB | Macleods Pharmaceuticals Limited | 9b654f0d-7705-4880-9e9d-ad3a51e56b56 | 2026-08-06 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| Tofacitinib | TOFACITINIB | Apotex Corp. | 7d4f5cfa-35a8-1458-a609-f6b417946abb | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| TOFACITINIB | TOFACITINIB | Micro Labs Limited | ffa6819b-23a4-478b-8fb7-cc90e8142fc5 | 2026-07-31 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB |
| tofacitinib | TOFACITINIB | Zydus Pharmaceuticals USA Inc. | 21a89264-8047-40ac-8b10-fa6461072509 | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | tofacitinib |
| TOFACITINIB | TOFACITINIB | Sun Pharmaceutical Industries, Inc. | a764a133-b870-4514-bbee-24d43f8cb7fd | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB |
| Tofacitinib | TOFACITINIB | Apotex Corp. | dd62a2b8-300b-d92b-7b27-a30eaa68fdd3 | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| Tofacitinib | TOFACITINIB | AvKARE | 5751321a-c904-44ae-e063-6394a90a2654 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | Radha Pharmaceuticals, Inc. | 141ab3eb-982b-4242-89db-6ddce5be0c40 | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB CITRATE |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | ScieGen Pharmaceuticals, INC. | 11d08738-efa3-4474-8eda-812bc04adfbb | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB CITRATE |
| TOFACITINIB | TOFACITINIB | Aurobindo Pharma Limited | e54b186f-e42a-4477-939c-8dd331045fbe | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB |
| TOFACITINIB | TOFACITINIB | Aurobindo Pharma Limited | 50962b08-99dd-ae73-e063-6394a90ad1eb | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB |
| TOFACITINIB | TOFACITINIB | IPG Pharmaceuticals, Inc | cd1b61bf-de03-4198-89f6-f3952b79d2c2 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB |
| TOFACITINIB | TOFACITINIB | Orient Pharma Co., Ltd. Yunlin Plant | 5617a652-a78e-74b1-e063-6394a90a31c7 | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB |
| Tofacitinib | TOFACITINIB | AvKARE | 5502f252-2b39-2cfd-e063-6394a90a8a48 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| Tofacitinib | TOFACITINIB | Ajanta Pharma USA Inc. | 024bb9f2-8c26-4d9d-a33b-eb3c0a7c59ed | 2026-06-05 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |